Week in Review: The Latest from PhRMA

Read the latest from PhRMA!

Priscilla VanderVeerAugust 7, 2015

Week in Review: The Latest from PhRMA.

week-in-reviewGAO: Prescription Drugs Are Just 2% of Medicaid Spending: The Government Accountability Office reported that fee-for-service drugs accounted for only 1.7 percent of Medicaid expenditures in 2014. Prescription medicines represent a small share of Medicaid spending and are not a main driver of Medicaid spending growth. Find out more here.

The Future of Clinical Pathways: With appropriate use, clinical pathways can improve patient outcomes, but the future is uncertain. As providers and payers increasingly utilize clinical pathways, it is important that these pathways serve as a resource for clinicians and not a restriction on the care patients receive. Check it out here.

Prescription Drug Prices Fall Significantly Over Time: Biopharmaceutical companies invest in innovative research to bring new treatments to patients, and over time those medicines become available as lower-cost generic copies. Learn about the impact of generics here.

Health Care Policy Developments: Learn about recent legislative and legal action that seeks to improve both patient care and the efficiency of the US healthcare system here.

Medicare Monday: Did you know four out of five Part D prescriptions are generic? Since Part D’s implementation, generic utilization reached 84 percent in 2013. Learn more here.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.